instruction
stringlengths
33
156
input
float64
output
stringlengths
120
1.97k
Does Adalimumab and Acetaminophen interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Acetaminophen can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Acetylsalicylic acid interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Acyclovir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Acyclovir can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Aducanumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Aducanumab, and the severity of the interaction is minor.
Does Adalimumab and Agomelatine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Agomelatine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Albendazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Albendazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Aldesleukin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Alectinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Alectinib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Alemtuzumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Alemtuzumab, and the severity of the interaction is major.
Does Adalimumab and Alfentanil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Alfentanil can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Alirocumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Alirocumab, and the severity of the interaction is minor.
Does Adalimumab and Allogeneic processed thymus tissue interact?
null
Allogeneic processed thymus tissue for immune reconstitution therapy aims to restore the immune function of patients with severe immunodeficiency caused by congenital athymia. The concomitant use of immunosuppressive agents may interfere with the therapeutic efficacy of immune reconstitution therapy. In short, The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Adalimumab, and the severity of the interaction is minor.
Does Adalimumab and Almotriptan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Almotriptan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Alogliptin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Alogliptin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Alosetron interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Alosetron can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Alpelisib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Alpelisib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Alprazolam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Alprazolam can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Ambrisentan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Ambrisentan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Aminophylline interact?
null
According to the FDA label for adalimumab 5 the formation of CYP450 enzymes may be suppressed by increased levels of cytokines (for example, TNFα, IL-6) during chronic inflammation. It is possible for a drug that antagonizes cytokine activity, such as adalimumab, to influence the formation of CYP450 enzymes, increasing the metabolism of xanthine derivatives. These drugs are primarily metabolized by CYP450 enzymes. In short, The serum concentration of Aminophylline can be decreased when it is combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Amiodarone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Amiodarone can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Amitriptyline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Amitriptyline can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Amivantamab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Amivantamab, and the severity of the interaction is minor.
Does Adalimumab and Amodiaquine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Amodiaquine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Amoxapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Amoxapine can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Amphetamine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Amphetamine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Amsacrine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Amsacrine, and the severity of the interaction is major.
Does Adalimumab and Anagrelide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Anagrelide can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Anakinra interact?
null
Since adalimumab and abatacept are both immunosuppressants, co-administration of adalimumab and anakinra can increase the risk of infection. In short, The risk or severity of infection can be increased when Adalimumab is combined with Anakinra, and the severity of the interaction is moderate.
Does Adalimumab and Anastrozole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Anastrozole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Anifrolumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Anifrolumab, and the severity of the interaction is major.
Does Adalimumab and Ansuvimab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Ansuvimab, and the severity of the interaction is minor.
Does Adalimumab and Anthrax immune globulin human interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Anthrax vaccine interact?
null
In a placebo-controlled clinical trial of patients with RA, no difference was detected in antipneumococcal antibody response between adalimumab and placebo treatment groups when the pneumococcal polysaccharide vaccine and influenza vaccine were administered concurrently with adalimumab. Similar proportions of patients developed protective levels of anti-influenza antibodies between adalimumab and placebo treatment groups; however, titers in aggregate to influenza antigens were moderately lower in patients receiving adalimumab. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Anthrax vaccine, and the severity of the interaction is minor.
Does Adalimumab and Antilymphocyte immunoglobulin (horse) interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Antilymphocyte immunoglobulin (horse), and the severity of the interaction is major.
Does Adalimumab and Antipyrine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Antipyrine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Antithymocyte immunoglobulin (rabbit) interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Antithymocyte immunoglobulin (rabbit), and the severity of the interaction is major.
Does Adalimumab and Apalutamide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Apalutamide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Apixaban interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Apixaban can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Apomorphine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Apomorphine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Apremilast interact?
null
The concomitant administration of apremilast with biologics for rheumatoid arthritis treatment has not been formally evaluated. Several studies have demonstrated that biologic agents frequently used in the treatment of psoriasis or rheumatoid arthritis may impact the metabolism of hepatic cytochrome enzyme substrates (such as apremilast) by stimulating cytochrome enzyme activities. Apremilast is a CYP3A4 substrate, and induction of this enzyme may lead to decreased therapeutic efficacy resulting from increased metabolism. In short, The therapeutic efficacy of Apremilast can be decreased when used in combination with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Aprepitant interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Aprepitant can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Arformoterol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Arformoterol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Aripiprazole lauroxil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Aripiprazole lauroxil can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Aripiprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Aripiprazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Arsenic trioxide interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Arsenic trioxide, and the severity of the interaction is major.
Does Adalimumab and Asenapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Asenapine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Asfotase alfa interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Asfotase alfa, and the severity of the interaction is minor.
Does Adalimumab and Astemizole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates with a narrow therapeutic index. In short, The metabolism of Astemizole can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and AstraZeneca COVID-19 Vaccine interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Asunaprevir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Asunaprevir can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Atazanavir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Atazanavir can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Atenolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Atenolol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Atezolizumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Atezolizumab, and the severity of the interaction is minor.
Does Adalimumab and Atomoxetine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Atomoxetine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Atorvastatin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Atorvastatin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Avacopan interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Avacopan, and the severity of the interaction is major.
Does Adalimumab and Avanafil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avanafil can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Avapritinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avapritinib can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Avatrombopag interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Avatrombopag can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Avelumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Avelumab, and the severity of the interaction is minor.
Does Adalimumab and Axitinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Axitinib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Azacitidine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine, and the severity of the interaction is major.
Does Adalimumab and Azathioprine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Azathioprine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Azelastine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Azelastine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Azithromycin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Azithromycin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Bacillus calmette-guerin substrain russian BCG-I live antigen interact?
null
VERITY-BCG is a live BCG vaccine used in the treatment of bladder cancer. In order to exert its therapeutic effect, intravesically-administered live BCG vaccines require the development of an immune response - its coadministration with immunosuppressive agents, such as the subject drug, may therefore interfere with anti-tumor efficacy by dampening the desired immune response. In short, The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Bacillus calmette-guerin substrain tice live antigen interact?
null
In a placebo-controlled clinical trial of patients with RA, no difference was detected in antipneumococcal antibody response between adalimumab and placebo treatment groups when the pneumococcal polysaccharide vaccine and influenza vaccine were administered concurrently with adalimumab. Similar proportions of patients developed protective levels of anti-influenza antibodies between adalimumab and placebo treatment groups; however, titers in aggregate to influenza antigens were moderately lower in patients receiving adalimumab. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bacillus calmette-guerin substrain tice live antigen, and the severity of the interaction is minor.
Does Adalimumab and Bamlanivimab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bamlanivimab, and the severity of the interaction is minor.
Does Adalimumab and Baricitinib interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib, and the severity of the interaction is major.
Does Adalimumab and Basiliximab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Basiliximab, and the severity of the interaction is major.
Does Adalimumab and BCG vaccine interact?
null
In a placebo-controlled clinical trial of patients with RA, no difference was detected in antipneumococcal antibody response between adalimumab and placebo treatment groups when the pneumococcal polysaccharide vaccine and influenza vaccine were administered concurrently with adalimumab. Similar proportions of patients developed protective levels of anti-influenza antibodies between adalimumab and placebo treatment groups; however, titers in aggregate to influenza antigens were moderately lower in patients receiving adalimumab. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with BCG vaccine, and the severity of the interaction is minor.
Does Adalimumab and Beclomethasone dipropionate interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Beclomethasone dipropionate, and the severity of the interaction is major.
Does Adalimumab and Belantamab mafodotin interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Belantamab mafodotin, and the severity of the interaction is minor.
Does Adalimumab and Belatacept interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Belatacept, and the severity of the interaction is major.
Does Adalimumab and Belimumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Belimumab, and the severity of the interaction is major.
Does Adalimumab and Belinostat interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Belinostat, and the severity of the interaction is major.
Does Adalimumab and Belumosudil interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Belumosudil, and the severity of the interaction is major.
Does Adalimumab and Belzutifan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Belzutifan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Bendamustine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Bendamustine can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Benralizumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab, and the severity of the interaction is minor.
Does Adalimumab and Benzatropine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Benzatropine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Benzocaine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Benzocaine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Benzphetamine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Benzphetamine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Benzyl alcohol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Benzyl alcohol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Besilesomab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Besilesomab, and the severity of the interaction is minor.
Does Adalimumab and Betamethasone interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Betamethasone, and the severity of the interaction is major.
Does Adalimumab and Betaxolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Betaxolol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Bevacizumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab, and the severity of the interaction is minor.
Does Adalimumab and Bexarotene interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Bexarotene can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Bezlotoxumab interact?
null
Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab, and the severity of the interaction is minor.
Does Adalimumab and Bicalutamide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bicalutamide can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Bimekizumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab, and the severity of the interaction is major.
Does Adalimumab and Binimetinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Binimetinib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Bleomycin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin, and the severity of the interaction is major.
Does Adalimumab and Blinatumomab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab, and the severity of the interaction is major.
Does Adalimumab and Bortezomib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bortezomib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Bosentan interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Bosentan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.
Does Adalimumab and Bosutinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Bosutinib can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Brentuximab vedotin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab, and the severity of the interaction is major.
Does Adalimumab and Brexpiprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Brexpiprazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.